Apixaban

TENDER DESCRIPTION

The subject of this publication is the conclusion of agreements pursuant to § 130a para. 8 SGB V for various active substances/active substance combinations within the framework of a so-called Open House procedure. Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a rebate contract pursuant to § 130a para. 8 SGB V for the specified active substance/active substance combination. Interested pharmaceutical companies can, after registration, download the tender documents (participation documents and contract) at: https://www.dtvp.de/Satellite/notice/CXP4Y6MM346. The e-mail address named in the contracting authority section for the purpose of unrestricted and complete free access to the tender documents is no longer valid. Information is only available via your registration on the award platform "DTVP" under the communication tab. Information and answers from other sources are not binding. A prerequisite for concluding a contract is that the interested pharmaceutical company submits the required procedural…

TENDER BRIEF

TENDER DOCUMENTS